0%
0%
0%
0%
0%
−0.0340USD
5.095MUSD
179.018M
About Oncotelic Therapeutics, Inc.
Sector
Industry
CEO
Vuong Trieu
Website
Headquarters
Agoura Hills
Employees
22
Founded
1988
ISIN
US6283411097
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
